{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:06:32Z","timestamp":1780455992730,"version":"3.54.1"},"reference-count":43,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"unspecified","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"University of Calgary Catalyst Grant"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2026,5,3]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Interstitial lung abnormalities (ILAs) are incidental parenchymal findings detected on CT scans. There is an estimated 4%\u201317%\u2009prevalence of ILAs in lung cancer screening (LCS) cohorts, associated with increased all-cause mortality. A substantial proportion of fibrotic ILAs progresses to interstitial lung disease (ILD), offering an important opportunity for early identification and management of ILD. However, current reporting and management strategies for ILAs are heterogeneous, underscoring the need for standardised approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To explore current practice patterns among primary care physicians (PCPs), respirologists and radiologists and to assess the need for a standardised care pathway for ILAs identified through LCS programmes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Online surveys and one-on-one semistructured interviews were conducted with PCPs, respirologists and radiologists practising in Alberta, Canada. Interviews were conducted using the Theoretical Domains Framework and Consolidated Framework for Implementation Research. Survey results are presented descriptively. Qualitative data were transcribed, coded and analysed according to grounded theory principles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 20 PCPs and 39 respirologists completed surveys while 9 PCPs, 10 respirologists and 8 radiologists were interviewed. Sixty-one per cent of PCPs had not heard of the term ILA previously and only 13% were comfortable managing ILAs. Most respirologists (64%) did not follow a standardised approach to managing ILAs. Most PCPs and respirologists supported the development of a standardised care pathway for ILAs detected through LCS. Thematic analysis explored current knowledge and perspectives on management, clinical approach and recommendations for future directions. Barriers to a standardised pathway included heterogeneous reporting, knowledge gaps in the natural history of ILAs and healthcare resource constraints.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This mixed-methods study provides valuable insight into the practice patterns and perceptions of PCPs, respirologists and radiologists regarding ILAs. Given the anticipated increase in ILA detection, we have conducted a needs assessment that will be foundational to building standardised care pathways for ILAs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2025-003761","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:50:12Z","timestamp":1780455012000},"page":"e003761","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating interstitial lung abnormality detection into lung cancer screening: a mixed methods approach for care pathway development"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5914-9374","authenticated-orcid":false,"given":"Da Hye","family":"Kim","sequence":"first","affiliation":[{"name":"Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Dinculescu","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Tremblay","sequence":"additional","affiliation":[{"name":"Division of Respirology, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavika","family":"Kaul","sequence":"additional","affiliation":[{"name":"Veterans Affairs Center for Innovation in Quality, Effectiveness and Safety, U.S. Department of Veterans Affairs, Houston, Texas, USA"},{"name":"Baylor College of Medicine, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri A","family":"Johannson","sequence":"additional","affiliation":[{"name":"Division of Respirology, University of Calgary, Calgary, Alberta, Canada"},{"name":"Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada"},{"name":"O\u2019Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Grant-Orser","sequence":"additional","affiliation":[{"name":"Division of Respirology, University of Calgary, Calgary, Alberta, Canada"},{"name":"Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada"},{"name":"O\u2019Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"2026060219500880000_13.1.e003761.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202505-1054ST"},{"key":"2026060219500880000_13.1.e003761.2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S2213-2600(20)30168-5","article-title":"Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society","volume":"8","author":"Hatabu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026060219500880000_13.1.e003761.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0518"},{"key":"2026060219500880000_13.1.e003761.4","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201512-2523OC"},{"key":"2026060219500880000_13.1.e003761.5","first-page":"140","article-title":"Prevalence and outcomes of interstitial lung abnormalities in a Canadian lung cancer screening trial","volume":"7","author":"Stuart","year":"2023","journal-title":"Can J Respir Crit Care Sleep Med"},{"key":"2026060219500880000_13.1.e003761.6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201809-1652OC"},{"key":"2026060219500880000_13.1.e003761.7","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13120816"},{"key":"2026060219500880000_13.1.e003761.8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2022-001490","article-title":"Diagnoses and treatments for participants with interstitial lung abnormalities detected in the Yorkshire Lung Screening Trial","volume":"10","author":"Upperton","year":"2023","journal-title":"BMJ Open Respir Res"},{"key":"2026060219500880000_13.1.e003761.9","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.11596"},{"key":"2026060219500880000_13.1.e003761.10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2024-002333","article-title":"The diagnostic pathway for patients with interstitial lung disease: a mixed-methods study of patients and physicians","volume":"11","author":"Grant-Orser","year":"2024","journal-title":"BMJ Open Respir Res"},{"key":"2026060219500880000_13.1.e003761.11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.chest.2021.06.035","article-title":"Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative","volume":"161","author":"Hunninghake","year":"2022","journal-title":"Chest"},{"key":"2026060219500880000_13.1.e003761.12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1164\/rccm.202302-0271OC","article-title":"Prevalence, Risk Factors, and Outcomes of Adult Interstitial Lung Abnormalities: A Systematic Review and Meta-Analysis","volume":"208","author":"Grant-Orser","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060219500880000_13.1.e003761.13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1513\/AnnalsATS.201801-053RL","article-title":"Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography","volume":"15","author":"Oldham","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"2026060219500880000_13.1.e003761.14","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1164\/rccm.202303-0410OC","article-title":"Long-Term Follow-Up of Interstitial Lung Abnormality: Implication in Follow-Up Strategy and Risk Thresholds","volume":"208","author":"Park","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060219500880000_13.1.e003761.15","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jacr.2019.03.006","article-title":"Application of Lung-Screening Reporting and Data System Versus Pan-Canadian Early Detection of Lung Cancer Nodule Risk Calculation in the Alberta Lung Cancer Screening Study","volume":"16","author":"Tremblay","year":"2019","journal-title":"J Am Coll Radiol"},{"key":"2026060219500880000_13.1.e003761.16","unstructured":"Screening For Life . Lung. 2025. Available: https:\/\/screeningforlife.ca\/lung\/"},{"key":"2026060219500880000_13.1.e003761.17","doi-asserted-by":"crossref","first-page":"100594","DOI":"10.1016\/j.jtocrr.2023.100594","article-title":"Health Care Utilization and Costs in Lung Cancer Screening Participants\u2014A Propensity-Matched Economic Analysis","volume":"4","author":"Tremblay","year":"2023","journal-title":"JTO Clinical and Research Reports"},{"key":"2026060219500880000_13.1.e003761.18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13012-017-0605-9","article-title":"A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems","volume":"12","author":"Atkins","year":"2017","journal-title":"Implementation Sci"},{"key":"2026060219500880000_13.1.e003761.19","doi-asserted-by":"publisher","DOI":"10.4997\/jrcpe.2015.305"},{"key":"2026060219500880000_13.1.e003761.20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","article-title":"The updated Consolidated Framework for Implementation Research based on user feedback","volume":"17","author":"Damschroder","year":"2022","journal-title":"Implementation Sci"},{"key":"2026060219500880000_13.1.e003761.21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1748-5908-9-11","article-title":"Discriminant content validity of a theoretical domains framework questionnaire for use in implementation research","volume":"9","author":"Huijg","year":"2014","journal-title":"Implement Sci"},{"key":"2026060219500880000_13.1.e003761.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312547"},{"key":"2026060219500880000_13.1.e003761.23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jacr.2023.03.023","article-title":"Variation in Reporting of Incidental Findings on Initial Lung Cancer Screening and Associations With Clinician Assessment","volume":"21","author":"Melzer","year":"2024","journal-title":"J Am Coll Radiol"},{"key":"2026060219500880000_13.1.e003761.24","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1513\/AnnalsATS.201612-1023OC","article-title":"Frequency of Incidental Findings and Subsequent Evaluation in Low-Dose Computed Tomographic Scans for Lung Cancer Screening","volume":"14","author":"Morgan","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2026060219500880000_13.1.e003761.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2023.09.009"},{"key":"2026060219500880000_13.1.e003761.26","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2015-207168","article-title":"British Thoracic Society guidelines for the investigation and management of pulmonary nodules","volume":"70 Suppl 2","author":"Callister","year":"2015","journal-title":"Thorax"},{"key":"2026060219500880000_13.1.e003761.27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jacr.2022.08.009","article-title":"A Quick Reference Guide for Incidental Findings on Lung Cancer Screening CT Examinations","volume":"20","author":"Dyer","year":"2023","journal-title":"J Am Coll Radiol"},{"key":"2026060219500880000_13.1.e003761.28","unstructured":"Lam S , Sam J . BC cancer lung screening standards and protocols. BC Cancer Lung Screening Provicinal Health Services Authority; 2023."},{"key":"2026060219500880000_13.1.e003761.29","unstructured":"McInnis M , Schmidt H , Ang M . Recommendations for the management of actionable incidental findings in the Ontario lung screening program. Cancer Care Ontario; 2021. Available: https:\/\/www.cancercareontario.ca\/en\/guidelines-advice\/types-of-cancer\/67226 [Accessed 12 Apr 2025]."},{"key":"2026060219500880000_13.1.e003761.30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.chest.2024.02.002","article-title":"Impact of Structured Reporting For Lung Cancer Screening Low-Dose CT Scan Incidental Findings on Physician Management","volume":"166","author":"Kunitomo","year":"2024","journal-title":"Chest"},{"key":"2026060219500880000_13.1.e003761.31","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0399ST"},{"key":"2026060219500880000_13.1.e003761.32","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202005-2032ST"},{"key":"2026060219500880000_13.1.e003761.33","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.chest.2024.09.033","article-title":"Interstitial Lung Abnormality","volume":"167","author":"Kattih","year":"2025","journal-title":"Chest"},{"key":"2026060219500880000_13.1.e003761.34","unstructured":"NHS England Lung Clinical Expert Advisory Group . Targeted screening for lung cancer with low radiation dose computed tomography. Standard protocol prepared for the Lung Cancer Screening Programme; 2025."},{"key":"2026060219500880000_13.1.e003761.35","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jtcvs.2017.07.086","article-title":"The economic impact of a nurse practitioner-directed lung cancer screening, incidental pulmonary nodule, and tobacco-cessation clinic","volume":"155","author":"Gilbert","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026060219500880000_13.1.e003761.36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2024.09.840","article-title":"EP.04A.01 Lung Cancer Nurse Consultant-Led Pulmonary Nodule Assessment and Surveillance Clinic: Multidisciplinary Team Evaluation","volume":"19","author":"Brunelli","year":"2024","journal-title":"J Thorac Oncol"},{"key":"2026060219500880000_13.1.e003761.37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21037\/ccts-20-47","article-title":"Challenges in lung cancer screening: a review of implemented programs","volume":"3","author":"Patel","year":"2021","journal-title":"Curr Chall Thorac Surg"},{"key":"2026060219500880000_13.1.e003761.38","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201705-392OC"},{"key":"2026060219500880000_13.1.e003761.39","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A3228","article-title":"Early Experience of a Dedicated Clinical Pathway for Interstitial Lung Abnormalities (ILAs)","volume":"211","author":"Shaw","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060219500880000_13.1.e003761.40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1513\/AnnalsATS.202102-216OC","article-title":"Travel Distance to Subspecialty Clinic and Outcomes in Patients with Fibrotic Interstitial Lung Disease","volume":"19","author":"Johannson","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2026060219500880000_13.1.e003761.41","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-024-02715-3","article-title":"Interstitial lung abnormality evaluated by an automated quantification system: prevalence and progression rate","volume":"25","author":"Oh","year":"2024","journal-title":"Respir Res"},{"key":"2026060219500880000_13.1.e003761.42","doi-asserted-by":"publisher","DOI":"10.1164\/RCCM.202110-2296OC"},{"key":"2026060219500880000_13.1.e003761.43","doi-asserted-by":"crossref","first-page":"109996","DOI":"10.1016\/j.clinimag.2023.109996","article-title":"Practice patterns in reporting interstitial lung abnormality at a tertiary academic medical center","volume":"104","author":"Escalon","year":"2023","journal-title":"Clin Imaging"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2025-003761","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:50:19Z","timestamp":1780455019000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2025-003761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6,2]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/bmjresp-2025-003761"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2025-003761","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}